Cite Filings / HQL / 0001104659-24-049993

Feed Companies Filings Check

Sign in

DEF 14A

Proxy Statement

abrdn Life Sciences Investors Filed 2024-04-22 Acc 0001104659-24-049993

Documents 1

DEF 14A Proxy Statement , tm2410797d15_def14a.htm

Around this filing

2025-04-14 DEF 14A Proxy Statement
2024-04-26 4 10% owner bought 118,103 shares at an average $13.01 ($1,536,827)
2024-04-23 4 10% owner bought 50,225 shares at an average $13.14 ($659,913)
2024-04-22 4 10% owner bought 124,197 shares at an average $12.81 ($1,591,420)
2024-04-22 DEF 14A Proxy Statement
2024-04-19 3 Initial Statement of Ownership
2023-07-10 DEF 14A Proxy Statement

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading tm2410797d15_def14a.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…